News

CUTISS launches Series C financing round to advance the development of its personalized skin technology, paving the way towards commercialization
September 18, 2023
0
THE COMMUNICATIONS STRATEGY GROUP INC., A LIFE SCIENCES CONSULTANCY, ANNOUNCES TWO NEW ADVISORY BOARD MEMBERS REFLECTIVE OF FIRM’S GROWING GLOBAL PRACTICE
September 12, 2023
0
Aardvark Therapeutics Announces Receipt of FDA Rare Pediatric Disease Designation for Prader-Willi Syndrome and Expands the Ongoing Phase 2 Clinical Trial
August 3, 2023
0
Aardvark Therapeutics Announces FDA Orphan Drug Designation Granted to ARD-101, a Novel Drug Candidate for Prader-Willi Syndrome
June 20, 2023
0
We need more than brain injury awareness: We need new treatment
April 4, 2023
0